Long-term d-allose administration ameliorates age-related cognitive impairment and loss of bone strength in male mice
Experimental Gerontology · 2024
DOI: 10.1016/j.exger.2024.112555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2024. Verfasst von Tomoya Shintani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Matsutani Chemical Industry Co., Ltd., 5-3 Kita-Itami, Itami City, Hyogo 664-8508, Japan. Hauptthemen laut MEDLINE: Hippocampus, Aging, Cognitive Dysfunction, Bone Density. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS.
Abstract (Originalsprache)
Age-related physical and cognitive decline may be ameliorated by consuming functional foods. d-Allose, reported to have multiple health benefits, may temper aging phenotypes, particularly brain function. We investigated whether d-allose supplementation improves cognitive function. A standard battery of behavioral tests was administered to 18-month-old male mice after consuming diet containing 3 % d-allose for 6 months. Following a wire-hanging test, an open-field test, Morris water maze, fear-conditioning, and an analgesia test were sequentially performed. Bone density and strength were assessed afterwards. Possible mechanism(s) under-lying memory changes in hippocampus were also examined with a DNA microarray. d-Allose failed to influence muscle strength, locomotor activity and anxiety, fear memory, or pain sensitivity. However, d-allose improved hippocampus-dependent spatial learning and memory, and it may contribute to increase bone strength. d-Allose also changed the expression of some genes in hippocampus involved in cognitive functions. Long-term d-allose supplementation appears to modestly change aging phenotypes and improve spatial memory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research and Development, Matsutani Chemical Industry Co., Ltd., 5-3 Kita-Itami, Itami City, Hyogo 664-8508, Japan.
- Aging Neuroscience Research Team, Tokyo Metropolitan Institute for Geriatrics and Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan; Animal Facility, Tokyo Metropolitan Institute for Geriatrics and Geronto…
- Research and Development, Matsutani Chemical Industry Co., Ltd., 5-3 Kita-Itami, Itami City, Hyogo 664-8508, Japan. Electronic address: akane-kanasaki@matsutani.co.jp.
- Aging Neuroscience Research Team, Tokyo Metropolitan Institute for Geriatrics and Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan.
Förderung
- JSPS
Zitieren
APA
Shintani, T., Yanai, S., Kanasaki, A., Iida, T., & Endo, S. (2024). Long-term d-allose administration ameliorates age-related cognitive impairment and loss of bone strength in male mice. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112555
Vancouver
Shintani T, Yanai S, Kanasaki A, Iida T, Endo S. Long-term d-allose administration ameliorates age-related cognitive impairment and loss of bone strength in male mice. Experimental Gerontology. 2024. doi:10.1016/j.exger.2024.112555
BibTeX
@article{Shintani2024,
author = {Shintani, Tomoya and Yanai, Shuichi and Kanasaki, Akane and Iida, Tetsuo and Endo, Shogo},
title = {Long-term d-allose administration ameliorates age-related cognitive impairment and loss of bone strength in male mice},
journal = {Experimental Gerontology},
year = {2024},
doi = {10.1016/j.exger.2024.112555}
}
EUVIMED